{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:48:17Z","timestamp":1791229697984,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007271","name":"Health Science Center, University of Tennessee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xops.2026.101199","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:48:42Z","timestamp":1776815322000},"page":"101199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deep Learning and Experimental Validation of BRCA1-Associated Protein-1 Missense Variant Pathogenicity in Uveal Melanoma"],"prefix":"10.1016","volume":"6","author":[{"given":"Nikhil","family":"Dav\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Taylor Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mak B.","family":"Djulbegovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Cernichiaro-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0652-4190","authenticated-orcid":false,"given":"Matthew W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2026.101199_bib1","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101199_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","article-title":"Advances in the clinical management of uveal melanoma","volume":"20","author":"Carvajal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.xops.2026.101199_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68232-7","article-title":"Forty-year prognosis after plaque brachytherapy of uveal melanoma","volume":"10","author":"Stalhammar","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2026.101199_bib4","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1038\/s41598-021-88390-6","article-title":"Estimation of the timing of BAP1 mutation in uveal melanoma progression","volume":"11","author":"Uner","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2026.101199_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s43856-022-00082-y","article-title":"Long-term relative survival in uveal melanoma: a systematic review and meta-analysis","volume":"2","author":"Stalhammar","year":"2022","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.xops.2026.101199_bib6","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41467-020-15606-0","article-title":"Molecular profiling of driver events in metastatic uveal melanoma","volume":"11","author":"Karlsson","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.xops.2026.101199_bib7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.xops.2026.101199_bib8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaophthalmol.2015.1119","article-title":"Clinical characteristics of uveal melanoma in patients with germline BAP1 mutations","volume":"133","author":"Gupta","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2026.101199_bib9","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","article-title":"Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma","volume":"119","author":"Onken","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101199_bib10","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1200\/JCO.24.00447","article-title":"15-Gene expression profile and PRAME as integrated prognostic test for uveal melanoma: first report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)","volume":"42","author":"Harbour","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.xops.2026.101199_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126027","article-title":"Intrinsic disorder may drive the interaction of PROS1 and MERTK in uveal melanoma","volume":"250","author":"Djulbegovic","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xops.2026.101199_bib12","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3390\/genes13101703","article-title":"Intrinsic disorder in BAP1 and its association with uveal melanoma","volume":"13","author":"Djulbegovic","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.xops.2026.101199_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clindermatol.2023.10.005","article-title":"The cancer genome atlas for uveal melanoma is predictive of patient outcomes","volume":"42","author":"Bas","year":"2024","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.xops.2026.101199_bib14","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.4103\/ijo.IJO_1589_19","article-title":"Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: a review","volume":"67","author":"Shields","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101199_bib15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jcjo.2025.05.017","article-title":"Metastasis-free survival outcomes of uveal melanoma based on the Cancer Genome Atlas classification in 1585 cases","volume":"60","author":"Shields","year":"2025","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101199_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.xops.2026.101199_bib17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.xops.2026.101199_bib18","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","article-title":"SF3B1 mutations are associated with alternative splicing in uveal melanoma","volume":"3","author":"Furney","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.xops.2026.101199_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1383125","article-title":"Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma","volume":"15","author":"Matull","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.xops.2026.101199_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cge.12630","article-title":"Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases","volume":"89","author":"Rai","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.xops.2026.101199_bib21","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xops.2026.101199_bib22","article-title":"AlphaMissense predictions and ClinVar annotations: a deep learning approach to uveal melanoma","volume":"5","author":"Gonzalez","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2026.101199_bib23","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41588-024-01799-3","article-title":"Saturation genome editing of BAP1 functionally classifies somatic and germline variants","volume":"56","author":"Waters","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.xops.2026.101199_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.xops.2026.101199_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xops.2026.101199_bib26","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jnci\/djy171","article-title":"Comprehensive Study of the clinical phenotype of germline BAP1 variant-carrying families worldwide","volume":"110","author":"Walpole","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.xops.2026.101199_bib27","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3390\/cancers11101579","article-title":"Prediction of BAP1 expression in uveal melanoma using densely-connected deep classification networks","volume":"11","author":"Sun","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xops.2026.101199_bib28","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s00259-025-07504-8","article-title":"Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [(18)F]FDG PET\/CT study","volume":"53","author":"Sachpekidis","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.xops.2026.101199_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejca.2022.07.031","article-title":"Machine learning models demonstrate that clinicopathologic variables are comparable to gene expression prognostic signature in predicting survival in uveal melanoma","volume":"174","author":"Donizy","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.xops.2026.101199_bib30","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"Consortium","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xops.2026.101199_bib31","series-title":"Data from: BAP1 SGE Dataset and Code (team113sanger\/Waters_BAP1_SGE)","author":"Waters","year":"2024"},{"key":"10.1016\/j.xops.2026.101199_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.xops.2026.101199_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13073-020-00803-9","article-title":"dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs","volume":"12","author":"Liu","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.xops.2026.101199_bib34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.xops.2026.101199_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13073-022-01120-z","article-title":"MetaRNN: differentiating rare pathogenic and rare benign missense SNVs and InDels using deep learning","volume":"14","author":"Li","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.xops.2026.101199_bib36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.xops.2026.101199_bib37","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome","volume":"47","author":"Rentzsch","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xops.2026.101199_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci"},{"key":"10.1016\/j.xops.2026.101199_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-018-0461-z","article-title":"Accurate classification of BRCA1 variants with saturation genome editing","volume":"562","author":"Findlay","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xops.2026.101199_bib40","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nmeth.3027","article-title":"Deep mutational scanning: a new style of protein science","volume":"11","author":"Fowler","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.xops.2026.101199_bib41","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20199380","article-title":"Using deep mutational scanning to benchmark variant effect predictors and identify disease mutations","volume":"16","author":"Livesey","year":"2020","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.xops.2026.101199_bib42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.xops.2026.101199_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13073-019-0690-2","article-title":"Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework","volume":"12","author":"Brnich","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.xops.2026.101199_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.xops.2026.101199_bib45","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2026.101199_bib46","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.ophtha.2007.06.012","article-title":"Cytogenetics of uveal melanoma: a 7-year clinical experience","volume":"114","author":"Damato","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101199_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-03915-7","article-title":"Presence of tumor DNA in aqueous humor is correlated with high risk uveal melanoma","volume":"15","author":"Barwinski","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2026.101199_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/iovs.65.1.15","article-title":"Expression of GNAQ, BAP1, SF3B1, and EIF1AX proteins in the aqueous humor of eyes affected by uveal melanoma","volume":"65","author":"Midena","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101199_bib49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/PAS.0000000000002176","article-title":"Prognostic value of BAP1 protein expression in uveal melanoma","volume":"48","author":"Kennedy","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.xops.2026.101199_bib50","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","article-title":"Biological mechanisms and clinical significance of BAP1 mutations in human cancer","volume":"10","author":"Carbone","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.xops.2026.101199_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41698-021-00226-8","article-title":"BAP1 methylation: a prognostic marker of uveal melanoma metastasis","volume":"5","author":"Bakhoum","year":"2021","journal-title":"NPJ Precis Oncol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526001375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526001375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:16:13Z","timestamp":1784103373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526001375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666914526001375"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101199","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep Learning and Experimental Validation of BRCA1-Associated Protein-1 Missense Variant Pathogenicity in Uveal Melanoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101199"}}